Spiriva (Boehringer) in Phase III for Asthma - 23-May-2012

Boehringer announced that a comprehensive confirmatory Phase III trial program named UniTinA-asthma is ongoing to fully evaluate the potential of the long-acting bronchodilator, Spiriva(tiotropium bromide)in the treatment of Asthma in pediatric, adolescent and adult patients.

Related News

Related Respiratory Information

Related Respiratory Drugs

Back to top

Latest News

10 May 2015
20 May 2013
20 May 2013